Press Releases

Roswell Park Comprehensive Cancer Center President and CEO Candace S. Johnson, PhD, has been named to City & State’s 2022 Health Care Power 100 list, released today. The weekly news magazine counts Dr. Johnson — who has been at the helm of Roswell Park since — as one of the “New York leaders who are saving lives.”

Today, the Ride for Roswell, presented by the West Herr Automotive Group, launched registration for the 2022 event, which will take place on Saturday, June 25 at the University at Buffalo. Online registration is available at www.rideforroswell.org. 

Metastasis, or spread of a cancer tumor from one organ to another, is a complex process about which much is still unknown. A collaborative research team led by scientists from Roswell Park Comprehensive Cancer Center and Wake Forest University Baptist Medical Center has determined that a small protein, RAC1, actively recruits enzymes involved in nucleotide production to promote cancer metastasis. Their findings, published in Nature Communications, suggest that targeting this interaction may provide a new strategy for treating advanced cancers.

A study led by scientists at Roswell Park Comprehensive Cancer Center shows that chemotherapy after surgery for gastric adenocarcinoma is significantly associated with longer survival in patients with chemosensitive disease, but not in those with very sensitive or refractory disease. These findings, which were recently published in the journal JAMA Network Open, suggest that assessing how responsive a tumor appears to be to treatment with chemotherapy before surgery can be used to guide decisions regarding postoperative chemotherapy, thereby personalizing treatment of patients with this type of stomach cancer.

African American men currently have the highest rates of prostate cancer in the United States and the poorest outcomes. New grants from the U.S. Department of Defense and American Cancer Society will fund work by two Roswell Park Comprehensive Cancer Center teams focused on understanding and eliminating prostate cancer health disparities.

A multidisciplinary team led by Roswell Park Comprehensive Cancer Center has identified troponin, a protein that enters the bloodstream only when the heart is damaged, as an early and reliable predictor of myocarditis in cancer patients receiving immunotherapy with immune checkpoint inhibitor (ICI) drugs. Findings of this retrospective study, which have been published in the Journal for ImmunoTherapy of Cancer, suggest that weekly troponin monitoring during the first six weeks of treatment could help physicians detect this rare but potentially fatal side effect of cancer immunotherapy.

With 2021 coming to a close, Roswell Park Comprehensive Cancer Center is proud to celebrate the 128 physicians across 33 specialties named to Buffalo Spree magazine’s Top Doctor’s list for 2022. Each year, the list is compiled through surveys submitted by Western New York physicians.

Since the introduction of electronic cigarettes, or e-cigarettes, to the United States in 2006, intense debate has surrounded the marketing, regulation and use of these nicotine-delivery products. Surprising new research led by Roswell Park Comprehensive Cancer Center has found that adult smokers with no plans to quit are more likely to quit smoking traditional combustible cigarettes if they switch to daily vaping.

Congressman Brian Higgins (NY-26) and Roswell Park CEO Dr. Candace Johnson recently joined a Congressional Cancer Caucus briefing with National Cancer Institute director Dr. Ned Sharpless and other national leaders discussing the National Cancer Act, which was signed into law on December 23, 1971, and efforts to continue making strides in cancer research and treatment.